arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Profusa, Inc.

PFSA
$2.08 ▲ +0.18 (+9.47%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
5 Visible periods
21 Metrics
Peer-ranked Benchmarks
Price Chart
57
Health
Fair
Bullish
auto_awesome

Analytical Summary

Profusa, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC 82.1% ↗
FCF / Share $-48.56 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

5-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-35.82M
↓ -311.2% —
FCF / Share Free cash flow per share
$-48.56
↓ -19348.3% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
100
Financial Health
13
Cash Quality
38

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 5 years · 21 quarters